Table 3.
Summary of failure reasons for primary effectiveness endpoint
| Reasons for primary effectiveness endpoint failure | n=138 |
| Residual aneurysm (n (%)) | 22 (15.9) |
| Residual neck (n (%)) | 3 (2.2) |
| Stenosis >50% (n (%)) | 4 (2.9) |
| Target aneurysm retreatment (n (%)) | 4 (2.9) |
| Total (n (%)) | 32 (23.2)* |
*One subject had both incomplete occlusion and retreatment.